Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
DOI: 10.1212/wnl.56.7.843
Authors: R. G. Miller, D. H. Moore, D. F. Gelinas, V. Dronsky, M. Mendoza, R. J. Barohn, W. Bryan, J. Ravits, E. Yuen, H. Neville, S. Ringel, M. Bromberg, J. Petajan, A. A. Amato, C. Jackson, W. Johnson, R. Mandler, P. Bosch, B. Smith, M. Graves, M. Ross, E. J. Sorenson, P. Kelkar, G. Parry, R. Olney, the WALS Study Group
Institutions: California Pacific Medical Center, University of California, San Francisco, The University of Texas Southwestern Medical Center, Virginia Mason Medical Center, University of Colorado Denver, University of Utah, The University of Texas at San Antonio Health Science Center, Oregon Health & Science University, University of New Mexico, Mayo Clinic, Mayo Clinic in Arizona, University of California, Los Angeles, University of Kentucky, University of Minnesota
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2001221763